Larvol Delta - FORMYCON-AND-BIOEQ-ANNOUNCE-SUBMISSION-OF-THE-BIOLOGICS-LICENSE-APPLICATION-BLA-FOR-FYB201-A-BIOSIMILAR-CANDIDATE-TO-LUCENTISR1-RANIBIZUMAB-TO-THE-US-FOOD-AND-DRUG-ADMINISTRATION-FDA

FYB201 (ranibizumab biosimilar) - Amneal, Formycon, Coherus, Teva

https://www.formycon.com/en/press-release/formycon-and-bioeq-announce-submission-of-the-biologics-license-application-bla-for-fyb201-a-biosimilar-candidate-to-lucentisr1-ranibizumab-to-the-u-s-food-and-drug-administration-fda/

Aug 5, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next